Loss of endothelial miR-126 drives age-related decline in hematopoiesis.
Abstract
Aging profoundly alters the bone marrow (BM) microenvironment and impairs hematopoietic stem cell (HSC) function. Here, we identify decrease of miR-126 derived from arteriolar endothelial cells (ECs) as a key mechanism of impaired HSC self-renewal capacity during aging. In young BM, arteriolar ECs express high levels of miR-126, which is transferred to HSCs and supports these cells' homeostasis and functional integrity. Using young and aged wild-type, endothelial-specific miR-126 knockout (EC-miR-126 KO), EC-Spred1 knockout (a functional model of EC-miR-126 upregulation), and EC/Sca-1 dual fluorescent reporter mice, we show that age-related increase in inflammatory cytokines (such as TNFα) reduces EC miR-126 expression and in turn drives loss of miR-126high CD31+Sca-1high EC-lined arterioles in the aging BM niche. Loss of arterioles in turn decreases the EC miR-126 supply to HSCs, leading to expansion of HSCs with limited self-renewal capacity. Remarkably, administration of a synthetic miR-126 mimic oligonucleotide restores EC-HSC communication and rescues aging-related HSC dysfunction. Our findings uncover a novel, non-cell-autonomous mechanism of HSC aging and highlight EC-derived miR-126 as a promising therapeutic target to rejuvenate hematopoiesis.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that loss of endothelial miR-126 contributes to impaired hematopoietic stem cell function during aging. This research addresses a mechanism underlying age-related decline in hematopoiesis, which is directly related to the aging process and potential rejuvenation strategies.
Author of this paper? Send a correction.